Nanotechnology and Drug Delivery Part 1: Background and Applications

Nanotechnology in general and as it relates to drug delivery in humans has been reviewed in a two-part article, the first part of which is this paper. In this paper, nanotechnology in nature, history of nanotechnology and methods of synthesis are discussed, while also outlining its applications, benefits and risks. Nanotechnology is an industrial revolution, based on integration of disciplines that could change every facet of human life. Some examples ofchanges brought about by reduction in particle sizes to the physical, chemical and biological properties of substances, compounds and drug products have been cited. The benefits of nanotechnology are enormous and so these benefits should be maximized while efforts are made to reduce the risks

Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery

This is the second part of a review on nanotechnology in general and particularly as it pertains to drug deliver. In the earlier paper (Part 1), nanotechnology in nature, its history as well as design and methodswere discussed. Its applications, benefits and risks were also outlined. In this paper (Part 2), various nanostructures employed in drug delivery, their methods of fabrication and challenges of nano drug delivery are reviewed. Nanotechnology is one approach to overcome challenges of conventional drugdelivery systems based on the development and fabrication of nanostructures. Some challenges associated with the technology as it relates to drug effectiveness, toxicity, stability, pharmacokinetics and drug regulatory control are discussed in this review. Clearly, nanotechnology is a welcomedevelopment that is set to transform drug delivery and drug supply chain management, if optimally developed

An assessment of pharmaceutical waste management in some Nigerian pharmaceutical industries

Thirty four (34) of the fifty (50) selected Nigerian based pharmaceutical businesses, mainly acting as local manufacturers and major importers of medicines were interviewed using questionnaires to ascertain their waste management practices, knowledge of waste management policies and subjection to regulatory control. This study indicated that like its counterpart industry in other countries of the world, the Nigerian pharmaceutical industry generated both hazardous and non-hazardous wastes. However, the wastes were not categorized, poorly managed by 91.2% of the respondents, while 58.8% of the health and safety personnel had little or no modern knowledge of waste management. Furthermore, 73.5% of the respondents claimed that they were aware of the regulatory requirements on waste, but no adherence was observed. The industry did not benefit from the strict supervisions of regulatory agencies. Pharmaceutical waste was improperly disposed and all the secondary manufacturers (79.4%) discharged wastewater without removal of pharmaceuticals. This study highlighted the urgent need to train personnel in the pharmaceutical industry and regulatory authorities. Management of waste should be planned, documented, implemented and sustained.Key words: Pharmaceutical waste, pharmaceuticals, wastewater, waste management, environment, regulatory authorities, effluent

Hypoglycemic effects of the aqueous extract of African Mistletoe, Tapinanthus sesselifolius (P. Beauv) van Tiegh (Loranthaceae)

The hypoglycemic effect of the aqueous extract of African mistletoe, Tapinanthus sesselifolius, was investigated in-vivo and in-vitro. Studies were carried out on normoglycemic and alloxan-induced hyperglycemic rabbits, and glucose uptake studies were done using the isolated intestine of normal rabbits. The safety studies (acute toxicity test) were carried out in mice. The results revealed that the aqueous extract of Tapinanthus sesselifolius exhibited transient reduction of blood glucose in normoglycemic rabbits and significantly lowered blood glucose level in hyperglycemic rabbits. The extract significantly decreased the level of glucose in serosal fluid dose dependently. The intraperitoneal (i.p.) LD50 of Tapinanthus sesselifolius was found to be 2000 – 2650 mg/kg within 95% confidence limits. The preliminary phytochemical screening showed positive test for biologically active substances such as saponins, tannins, flavonoids, terpenoids and glycosides. The data showed that Tapinanthus sesselifolius contain biologically active substances that may be useful in treatment of diabetes and thus gave a scientific basis for its use in herbal traditional medicine as an antidiabetic agent.Keywords: Phytomedicine, alloxan-induced hyperglycemia, glucose uptak

New potential antitumoral fluorescent tetracyclic thieno[3,2-b]pyridine derivatives: interaction with DNA and nanosized liposomes

Fluorescence properties of two new potential antitumoral tetracyclic thieno[3,2-b]pyridine derivatives were studied in solution and in liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from egg yolk; Egg-PC) and DODAB (dioctadecyldimethylammonium bromide). Compound 1, pyrido[2',3':3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-one, exhibits reasonably high fluorescence quantum yields in all solvents studied (0.20 ≤ ΦF ≤ 0.30), while for compound 2, 3-[(p-methoxyphenyl)ethynyl]pyrido[2',3':3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-one, the values are much lower (0.01 ≤ ΦF ≤ 0.05). The interaction of these compounds with salmon sperm DNA was studied using spectroscopic methods, allowing the determination of intrinsic binding constants, Ki = (8.7 ± 0.9) × 103 M-1 for compound 1 and Ki = (5.9 ± 0.6) × 103 M-1 for 2, and binding site sizes of n = 11 ± 3 and n = 7 ± 2 base pairs, respectively. Compound 2 is the most intercalative compound in salmon sperm DNA (35%), while for compound 1 only 11% of the molecules are intercalated. Studies of incorporation of both compounds in liposomes of DPPC, Egg-PC and DODAB revealed that compound 2 is mainly located in the hydrophobic region of the lipid bilayer, while compound 1 prefers a hydrated and fluid environment

Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin

In bone disorders infections are common. The concentration of majority of antibiotics is very low in the bone tissue. A high local dose can be obtained from the ciprofloxacin-loaded hydroxyapatite nanoparticles. The present study is aimed at developing the use of hydroxyapatite and zinc-doped hydroxyapatite nanoparticles as a carrier for ciprofloxacin drug delivery system. The ciprofloxacin-loaded hydroxyapatite and zinc-doped hydroxyapatite have a good antibacterial activity against Pseudomonas aeruginosa and Staphylococcus aureus. Hydroxyapatite and zinc-doped hydroxyapatite were prepared and characterized using X-ray diffraction, Transmission electron microscopy and inductively coupled plasma optical emission spectrometry. They were loaded with ciprofloxacin using optimized drug loading parameters. Drug loading, in vitro drug release and antimicrobial activity were analyzed. The influence of zinc on the controlled release of ciprofloxacin was analyzed. The results show that the presence of zinc increases the drug release percentage and that the drug was released in a controlled manner

Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy

Despite the technological advancement in the biomedical science, cancer remains a life-threatening disease. In this study, we designed an anticancer nanodelivery system using graphene oxide (GO) as nanocarrier for an active anticancer agent gallic acid (GA). The successful formation nanocomposite (GOGA) was characterized using XRD, FTIR, HRTEM, Raman, and UV/Vis spectroscopy. The release study shows that the release of GA from the designed anticancer nanocomposite (GOGA) occurs in a sustained manner in phosphate-buffered saline (PBS) solution at pH 7.4. In in vitro biological studies, normal fibroblast (3T3) and liver cancer cells (HepG2) were treated with different concentrations of GO, GOGA, and GA for 72 h. The GOGA nanocomposite showed the inhibitory effect to cancer cell growth without affecting normal cell growth. The results of this research are highly encouraging to go further for in vivo studies